poloxamine 504 hamilelikte güvenli mi?
No authoritative reproductive hazard classification or safety assessment (SCCS/CIR/harmonised CLP) for Poloxamine 504 was identified, and published literature on poloxamines describes them as non‑reactive block copolymer surfactants used as excipients/carrier materials rather than reproductive toxicants. Searches of PubMed found formulation and delivery studies of poloxamines but no animal or human reproductive toxicity reports. Therefore default score is 0/0/0. (See PubMed discussion of poloxamines and supplier/cosmetic ingredient listings below).
Related ingredients
Frequently asked questions
- poloxamine 504 hamilelikte güvenli mi?
- No authoritative reproductive hazard classification or safety assessment (SCCS/CIR/harmonised CLP) for Poloxamine 504 was identified, and published literature on poloxamines describes them as non‑reactive block copolymer surfactants used as excipients/carrier materials rather than reproductive toxicants. Searches of PubMed found formulation and delivery studies of poloxamines but no animal or human reproductive toxicity reports. Therefore default score is 0/0/0. (See PubMed discussion of poloxamines and supplier/cosmetic ingredient listings below).
- poloxamine 504 emzirirken güvenli mi?
- No evidence found that poloxamine family members (including products marketed as Poloxamine/Tetronic) cause reproductive or lactation-related toxicity or have specific milk-transfer data. No harmonised CLP (ECHA Annex VI) classification or SCCS/CIR opinion indicating developmental or lactation hazards was found. In absence of positive data, default scores are 0/0/0. Sources include formulation and biocompatibility studies and supplier/cosmetic ingredient databases.
- poloxamine 504 bebek cildi için güvenli mi?
- No infant‑specific reproductive or developmental hazard evidence was located. Mechanistic evidence for reproductive toxicity is absent, so h/m remain 0. Exposure (e) is increased by +1 for baby skin because poloxamines are surfactant/block copolymers with some potential for dermal uptake when used topically (and infant skin has higher absorption per weight); absorption is generally low but measurable in topical formulations described in the literature, so baby_skin e=1.
- VeriMom poloxamine 504 nasıl puanlıyor?
- VeriMom poloxamine 504'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte poloxamine 504 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.